This study evaluated whether or not serum and GCF levels of sclerostin, RANKL, MMP-9, and PGE2—all biomarkers and proteins with important roles in the pathophysiology of AP—could be used in the diagnosis and follow-up of AP lesions of different severity. The gene discussed is SOST; the disease is alkaline phosphatase measurement.